Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH

Nature Cell Biology

Volumn 16, Issue 7, 2014, Pages 685-694

  Urosevic, Jelena ^a   Garcia Albéniz, Xabier ^a,b   Planet, Evarist ^a   Real, Sebastián ^a   Céspedes, María Virtudes ^c,d   Guiu, Marc ^a   Fernandez, Esther ^a   Bellmunt, Anna ^a   Gawrzak, Sylwia ^a   Pavlovic, Milica ^a   Mangues, Ramon ^c,d   Dolado, Ignacio ^a,g   Barriga, Francisco M ^a   Nadal, Cristina ^b   Kemeny, Nancy ^e   Batlle, Eduard ^a,f   Nebreda, Angel R ^a,f   Gomis, Roger R ^a,f  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^g MOLECULAR PARTNERS AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PARATHYROID HORMONE LIKE HORMONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL ACTIVITY; CELL DEATH; CELLULAR DISTRIBUTION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; LIVER METASTASIS; LUNG ENDOTHELIUM; LUNG METASTASIS; MICROVASCULATURE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; MUTATION; NEOPLASM METASTASIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARATHYROID HORMONE-RELATED PROTEIN; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 84903793785     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2977     Document Type: Article

References (42)

1. Edge, S. B., Byrd, D. R., Compton, C. C. & Fritz, A. G. AJCC Cancer Staging Manual (Springer, 2009).
2. Gallagher, D. J. & Kemeny, N. Metastatic colorectal cancer: from improved survival to potential cure. Oncology 78, 237-248 (2010).
3. Wanebo, H. J. et al. Meeting the biologic challenge of colorectal metastases. Clin. Exp. Metastasis 29, 821-839 (2012).
4. Sadahiro, S. et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology 50, 1362-1366 (2003).
5. Kievit, J. Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur. J. Cancer 38, 986-999 (2002).
6. Nguyen, D. X., Bos, P. D. & Massagué, J. Metastasis: from dissemination to organspecific colonization. Nat. Rev. Cancer 9, 274-284 (2009).
7. Tie, J. et al. KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer. Clin. Cancer Res. 17, 1122-1130 (2011).
8. Schlüter, K. et al. Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. Am. J. Pathol. 169, 1064-1073 (2006).
9. Ding, L. et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999-1005 (2010).
10. Fidler, I. J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3, 453-458 (2003).
11. Kaiser, S. et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol. 8, R131 (2007).
12. Smith, J. J. et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138, 958-968 (2010).
13. Merlos-Suárez, A. et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8, 511-524 (2011).
14. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
15. Wagner, E. F. & Nebreda, A. R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537-549 (2009).
16. Cuadrado, A. & Nebreda, A. R. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429, 403-417 (2010).
17. Shin, S., Dimitri, C. A., Yoon, S-O., Dowdle, W. & Blenis, J. ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol. Cell 38, 114-127 (2010).
18. Xing, L. et al. Discovery and characterization of atropisomer PH-797804, a p38 MAP kinase inhibitor, as a clinical drug candidate. Chem. Med. Chem. 7, 273-280 (2012).
19. Céspedes, M. V. et al. Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am. J. Pathol. 170, 1077-1085 (2007).
20. Adams, S. L., Cohen, A. J. & Lassová, L. Integration of signaling pathways regulating chondrocyte differentiation during endochondral bone formation. J. Cell. Physiol. 213, 635-641 (2007).
21. Hens, J. R. et al. BMP4 and PTHrP interact to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction. Development 134, 1221-1230 (2007).
22. Norberg, E. et al. An increase in intracellular Ca2C is required for the activation of mitochondrial calpain to release AIF during cell death. Cell Death Differ. 15, 1857-1864 (2008).
23. Sanges, D., Comitato, A., Tammaro, R. & Marigo, V. Apoptosis in retinal degeneration involves cross-talk between apoptosis-inducing factor (AIF) and caspase-12 and is blocked by calpain inhibitors. Proc. Natl Acad. Sci. USA 103, 17366-17371 (2006).
24. Vilardaga, J-P., Romero, G., Friedman, P. A. & Gardella, T. J. Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm. Cell. Mol. Life Sci. 68, 1-13 (2011).
25. Susin, S. A. et al. Two distinct pathways leading to nuclear apoptosis. J. Exp. Med. 192, 571-580 (2000).
26. Joza, N. et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410, 549-554 (2001).
27. Gallwitz, W. E., Guise, T. A. & Mundy, G. R. Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo. J. Clin. Invest. 110, 1559-1572 (2002).
28. Takayama, Y., Mori, T., Nomura, T., Shibahara, T. & Sakamoto, M. Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma. Int. J. Oncol. 36, 1387-1394 (2010).
29. Guise, T. A. Molecular mechanisms of osteolytic bone metastases. Cancer 88, 2892-2898 (2000).
30. Malakouti, S., Asadi, F. K., Kukreja, S. C., Abcarian, H. A. & Cintron, J. R. Parathyroid hormone-related protein expression in the human colon: immunohistochemical evaluation. Am. Surg. 62, 540-544 (1996).
31. Ponomarev, V. et al. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur. J. Nucl. Med. Mol. Imaging 31, 740-751 (2004).
32. Giavazzi, R., Campbell, D. E., Jessup, J. M., Cleary, K. & Fidler, I. J. Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res. 46, 1928-1933 (1986).
33. Céspedes, M. V. et al. Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am. J. Pathol. 170, 1077-1085 (2007).
34. Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).
35. Rossell, D., Guerra, R. & Scott, C. Semi-parametric differential, expression analysis via partial mixture estimation. Stat. Appl. Genet. Mol. Biol. 7, Article15 (2008).
36. Mallick, B. K., Gold, D. & Baladandayuthapani, V. Bayesan Analysis of Gene Expression Data (Wiley, 2009).
37. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. Ser. B 57, 289-300 (1995).
38. Alonso, G., Ambrosino, C., Jones, M. & Nebreda, A. R. Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength. J. Biol. Chem. 275, 40641-40648 (2000).
39. Garcia-Albeniz, X. et al. Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab. Tumour Biol. 32, 417-424 (2011).
40. Martínez-Fernandez, A. et al. Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients. Ann. Surg. Oncol. 16, 1412-1420 (2009).
41. Smith, J. J. et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138, 958-968 (2010).
42. Jorissen, R. N. et al. Metastasis-associated gene expression changes predict poor outcomes in patients with dukes stage B and C colorectal cancer. Clin. Cancer Res. 15, 7642-7651 (2009).